Reaching for high-hanging fruit in drug discovery at protein–protein interfaces View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-12-12

AUTHORS

James A. Wells, Christopher L. McClendon

ABSTRACT

Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-molecule drugs that disrupt protein–protein interactions is an enormous challenge. Several recent success stories, however, indicate that protein–protein interfaces might be more tractable than has been thought. These studies discovered small molecules that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein–protein interactions. Remarkably, these small molecules bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner. Some of these small molecules are now making their way through clinical trials, so this high-hanging fruit might not be far out of reach. More... »

PAGES

1001-1009

Journal

TITLE

Nature

ISSUE

7172

VOLUME

450

Related Patents

  • Heterocyclic Compounds As Immunomodulators
  • Heterocyclic Compounds As Immunomodulators
  • Methods Of Treating Inflammation With Monomeric Cxcl12 Peptide
  • Methods For Characterizing And Engineering Protein-Protein Interactions
  • Monomeric Cxcl121 Peptide And Methods Of Treating Autoimmune Diseases
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Pyrido[3,2-D]Pyrimidine Compounds As Immunomodulators
  • Heterocyclic Compounds As Immunomodulators
  • Modified Aminoacyl-Trna Synthetase And Use Thereof
  • Dosing For Treatment With Anti-Cd20/Anti-Cd3 Bispecific Antibodies
  • Small Molecule Regulators Of Steroid Receptor Coactivators And Methods Of Use Thereof
  • Pd-1 Antibody, Antigen-Binding Fragment Thereof, And Medical Application Thereof
  • Heterocyclic Compounds As Immunomodulators
  • Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-Mediated Disease
  • Peptide-Compound Cyclization Method
  • Heterocyclic Compounds As Immunomodulators
  • Heterocyclic Compounds As Immunomodulators
  • Two-Hybrid Based Screen To Identify Disruptive Residues At Multiple Protein Interfaces
  • Heterocyclic Compounds As Immunomodulators
  • Heterocyclic Compounds As Immunomodulators
  • Target Binding Molecules Identified By Kinetic Target-Guided Synthesis
  • Cell Free Methods For Detecting Protein-Ligand Binding
  • Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-Mediated Disease
  • Pharmaceutical Composition Containing A Mixture Of Proenzymes And Enzymes
  • Heterocyclic Compounds As Immunomodulators
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Bax-Activating Cancer Therapeutics
  • Chemical Synthesis And Screening Of Bicyclic Peptide Libraries
  • Heterocyclic Compounds As Immunomodulators
  • Compounds For Use As Bromodomain Inhibitors
  • Chemical Synthesis And Screening Of Bicyclic Peptide Libraries
  • Method For Screening New Drug Candidate Inhibiting Target Protein-Protein Interaction For Development Of First-In-Class Drug
  • Bicyclic Peptidyl Inhibitor Of Tumor Necrosis Factor-Alpha
  • High-Throughput Screening Methods To Identify Small Molecule Targets
  • Small Molecule Regulators Of Steroid Receptor Coactivators And Methods Of Use Thereof
  • Method For Screening New Drug Candidate Inhibiting Target Protein-Protein Interaction For Development Of First-In-Class Drug
  • Anti-Cd3 Antibodies And Methods Of Use
  • Small Molecule Regulators Of Steroid Receptor Coactivators And Methods Of Use Thereof
  • Two-Hybrid Based Screen To Identify Disruptive Residues At Multiple Protein Interfaces
  • Inhibitors Of Tnf Superfamily Costimulatory Interactions And Methods For Uses Of The Same
  • Monomeric Cxcl121 Peptide And Methods Of Use Thereof
  • Immunomodulator Compounds And Methods Of Use
  • Cyclic Peptides
  • Pd-1 Antibody, Antigen-Binding Fragment Thereof, And Medical Application Thereof
  • Heterocyclic Compounds As Immunomodulators
  • Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-Mediated Disease
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature06526

    DOI

    http://dx.doi.org/10.1038/nature06526

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1038231590

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18075579


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Chemical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0304", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medicinal and Biomolecular Chemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Binding Sites", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Evaluation, Preclinical", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Binding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Cellular and Molecular Pharmacology, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266102.1", 
              "name": [
                "Department of Pharmaceutical Chemistry, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA", 
                "Department of Cellular and Molecular Pharmacology, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wells", 
            "givenName": "James A.", 
            "id": "sg:person.014760316702.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014760316702.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Graduate Group in Biophysics, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266102.1", 
              "name": [
                "Graduate Group in Biophysics, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McClendon", 
            "givenName": "Christopher L.", 
            "id": "sg:person.0575550524.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575550524.75"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nature05649", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029295434", 
              "https://doi.org/10.1038/nature05649"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature04670", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033456836", 
              "https://doi.org/10.1038/nature04670"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature05201", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005761190", 
              "https://doi.org/10.1038/nature05201"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature03579", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025520673", 
              "https://doi.org/10.1038/nature03579"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd892", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046818756", 
              "https://doi.org/10.1038/nrd892"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:jnmr.0000048856.84603.9b", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005358874", 
              "https://doi.org/10.1023/b:jnmr.0000048856.84603.9b"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045526065", 
              "https://doi.org/10.1038/nbt1284"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-7643-7567-6_8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050304758", 
              "https://doi.org/10.1007/978-3-7643-7567-6_8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cdd.4401910", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045481166", 
              "https://doi.org/10.1038/sj.cdd.4401910"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1343", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040452458", 
              "https://doi.org/10.1038/nrd1343"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1273", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019548326", 
              "https://doi.org/10.1038/nbt1273"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature04104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041372966", 
              "https://doi.org/10.1038/nature04104"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1197-1266", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043846067", 
              "https://doi.org/10.1038/nbt1197-1266"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-12-12", 
        "datePublishedReg": "2007-12-12", 
        "description": "Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-molecule drugs that disrupt protein\u2013protein interactions is an enormous challenge. Several recent success stories, however, indicate that protein\u2013protein interfaces might be more tractable than has been thought. These studies discovered small molecules that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein\u2013protein interactions. Remarkably, these small molecules bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner. Some of these small molecules are now making their way through clinical trials, so this high-hanging fruit might not be far out of reach.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature06526", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2683890", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7172", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "450"
          }
        ], 
        "keywords": [
          "small molecules", 
          "protein-protein interfaces", 
          "natural protein partners", 
          "small molecule drugs", 
          "drug discovery", 
          "protein-protein interactions", 
          "molecules", 
          "recent success stories", 
          "contact atoms", 
          "target proteins", 
          "huge therapeutic potential", 
          "high efficiency", 
          "surface", 
          "interface", 
          "atoms", 
          "interaction", 
          "contact surface", 
          "protein partners", 
          "enormous challenges", 
          "clinical trials", 
          "therapeutic potential", 
          "potency", 
          "discovery", 
          "potential", 
          "efficiency", 
          "drugs", 
          "protein", 
          "trials", 
          "fruit", 
          "study", 
          "challenges", 
          "partners", 
          "way", 
          "hotspots", 
          "success stories", 
          "reach", 
          "story"
        ], 
        "name": "Reaching for high-hanging fruit in drug discovery at protein\u2013protein interfaces", 
        "pagination": "1001-1009", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1038231590"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature06526"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18075579"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature06526", 
          "https://app.dimensions.ai/details/publication/pub.1038231590"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_440.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature06526"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature06526'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature06526'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature06526'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature06526'


     

    This table displays all metadata directly associated to this object as RDF triples.

    194 TRIPLES      21 PREDICATES      83 URIs      60 LITERALS      13 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature06526 schema:about N0a90872677934fafa42c6069b6dee39d
    2 N598b8c44affa45c5822173b78598eb78
    3 N69ffb8de8fc44a3dade3e2ecdce519a8
    4 N6b73d777cf9d4461b7e980c727f6aaa0
    5 Na2519a7773b84ef8ad6d9fbdce484783
    6 Nc9318bc36941433090c45e77e00fbf95
    7 anzsrc-for:03
    8 anzsrc-for:0304
    9 anzsrc-for:06
    10 anzsrc-for:0601
    11 schema:author Na63f0581706148569a867954511ef8f9
    12 schema:citation sg:pub.10.1007/978-3-7643-7567-6_8
    13 sg:pub.10.1023/b:jnmr.0000048856.84603.9b
    14 sg:pub.10.1038/nature03579
    15 sg:pub.10.1038/nature04104
    16 sg:pub.10.1038/nature04670
    17 sg:pub.10.1038/nature05201
    18 sg:pub.10.1038/nature05649
    19 sg:pub.10.1038/nbt1197-1266
    20 sg:pub.10.1038/nbt1273
    21 sg:pub.10.1038/nbt1284
    22 sg:pub.10.1038/nrd1343
    23 sg:pub.10.1038/nrd892
    24 sg:pub.10.1038/sj.cdd.4401910
    25 schema:datePublished 2007-12-12
    26 schema:datePublishedReg 2007-12-12
    27 schema:description Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-molecule drugs that disrupt protein–protein interactions is an enormous challenge. Several recent success stories, however, indicate that protein–protein interfaces might be more tractable than has been thought. These studies discovered small molecules that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein–protein interactions. Remarkably, these small molecules bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner. Some of these small molecules are now making their way through clinical trials, so this high-hanging fruit might not be far out of reach.
    28 schema:genre article
    29 schema:isAccessibleForFree false
    30 schema:isPartOf N087ad6c385614defbe38123d90987d55
    31 Na23000ab92284d96a75884b2b3773bd6
    32 sg:journal.1018957
    33 schema:keywords atoms
    34 challenges
    35 clinical trials
    36 contact atoms
    37 contact surface
    38 discovery
    39 drug discovery
    40 drugs
    41 efficiency
    42 enormous challenges
    43 fruit
    44 high efficiency
    45 hotspots
    46 huge therapeutic potential
    47 interaction
    48 interface
    49 molecules
    50 natural protein partners
    51 partners
    52 potency
    53 potential
    54 protein
    55 protein partners
    56 protein-protein interactions
    57 protein-protein interfaces
    58 reach
    59 recent success stories
    60 small molecule drugs
    61 small molecules
    62 story
    63 study
    64 success stories
    65 surface
    66 target proteins
    67 therapeutic potential
    68 trials
    69 way
    70 schema:name Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
    71 schema:pagination 1001-1009
    72 schema:productId N2a924d7338764ec085faf7b5d02d1e8e
    73 N86ec60f7b10e4d9e9bccd3e39980bc70
    74 Nebd5c6645f044bfea1d5fe3e798ec412
    75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038231590
    76 https://doi.org/10.1038/nature06526
    77 schema:sdDatePublished 2022-11-24T20:53
    78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    79 schema:sdPublisher Na740cd1ba2964af2b14da20d1b42f815
    80 schema:url https://doi.org/10.1038/nature06526
    81 sgo:license sg:explorer/license/
    82 sgo:sdDataset articles
    83 rdf:type schema:ScholarlyArticle
    84 N087ad6c385614defbe38123d90987d55 schema:issueNumber 7172
    85 rdf:type schema:PublicationIssue
    86 N0a90872677934fafa42c6069b6dee39d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    87 schema:name Humans
    88 rdf:type schema:DefinedTerm
    89 N0cd7d381400544aca92062230b4f0a92 rdf:first sg:person.0575550524.75
    90 rdf:rest rdf:nil
    91 N2a924d7338764ec085faf7b5d02d1e8e schema:name pubmed_id
    92 schema:value 18075579
    93 rdf:type schema:PropertyValue
    94 N598b8c44affa45c5822173b78598eb78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Animals
    96 rdf:type schema:DefinedTerm
    97 N69ffb8de8fc44a3dade3e2ecdce519a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Proteins
    99 rdf:type schema:DefinedTerm
    100 N6b73d777cf9d4461b7e980c727f6aaa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Binding Sites
    102 rdf:type schema:DefinedTerm
    103 N86ec60f7b10e4d9e9bccd3e39980bc70 schema:name doi
    104 schema:value 10.1038/nature06526
    105 rdf:type schema:PropertyValue
    106 Na23000ab92284d96a75884b2b3773bd6 schema:volumeNumber 450
    107 rdf:type schema:PublicationVolume
    108 Na2519a7773b84ef8ad6d9fbdce484783 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Drug Evaluation, Preclinical
    110 rdf:type schema:DefinedTerm
    111 Na63f0581706148569a867954511ef8f9 rdf:first sg:person.014760316702.21
    112 rdf:rest N0cd7d381400544aca92062230b4f0a92
    113 Na740cd1ba2964af2b14da20d1b42f815 schema:name Springer Nature - SN SciGraph project
    114 rdf:type schema:Organization
    115 Nc9318bc36941433090c45e77e00fbf95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Protein Binding
    117 rdf:type schema:DefinedTerm
    118 Nebd5c6645f044bfea1d5fe3e798ec412 schema:name dimensions_id
    119 schema:value pub.1038231590
    120 rdf:type schema:PropertyValue
    121 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
    122 schema:name Chemical Sciences
    123 rdf:type schema:DefinedTerm
    124 anzsrc-for:0304 schema:inDefinedTermSet anzsrc-for:
    125 schema:name Medicinal and Biomolecular Chemistry
    126 rdf:type schema:DefinedTerm
    127 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    128 schema:name Biological Sciences
    129 rdf:type schema:DefinedTerm
    130 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    131 schema:name Biochemistry and Cell Biology
    132 rdf:type schema:DefinedTerm
    133 sg:grant.2683890 http://pending.schema.org/fundedItem sg:pub.10.1038/nature06526
    134 rdf:type schema:MonetaryGrant
    135 sg:journal.1018957 schema:issn 0028-0836
    136 1476-4687
    137 schema:name Nature
    138 schema:publisher Springer Nature
    139 rdf:type schema:Periodical
    140 sg:person.014760316702.21 schema:affiliation grid-institutes:grid.266102.1
    141 schema:familyName Wells
    142 schema:givenName James A.
    143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014760316702.21
    144 rdf:type schema:Person
    145 sg:person.0575550524.75 schema:affiliation grid-institutes:grid.266102.1
    146 schema:familyName McClendon
    147 schema:givenName Christopher L.
    148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575550524.75
    149 rdf:type schema:Person
    150 sg:pub.10.1007/978-3-7643-7567-6_8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050304758
    151 https://doi.org/10.1007/978-3-7643-7567-6_8
    152 rdf:type schema:CreativeWork
    153 sg:pub.10.1023/b:jnmr.0000048856.84603.9b schema:sameAs https://app.dimensions.ai/details/publication/pub.1005358874
    154 https://doi.org/10.1023/b:jnmr.0000048856.84603.9b
    155 rdf:type schema:CreativeWork
    156 sg:pub.10.1038/nature03579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025520673
    157 https://doi.org/10.1038/nature03579
    158 rdf:type schema:CreativeWork
    159 sg:pub.10.1038/nature04104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041372966
    160 https://doi.org/10.1038/nature04104
    161 rdf:type schema:CreativeWork
    162 sg:pub.10.1038/nature04670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033456836
    163 https://doi.org/10.1038/nature04670
    164 rdf:type schema:CreativeWork
    165 sg:pub.10.1038/nature05201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005761190
    166 https://doi.org/10.1038/nature05201
    167 rdf:type schema:CreativeWork
    168 sg:pub.10.1038/nature05649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029295434
    169 https://doi.org/10.1038/nature05649
    170 rdf:type schema:CreativeWork
    171 sg:pub.10.1038/nbt1197-1266 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043846067
    172 https://doi.org/10.1038/nbt1197-1266
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1038/nbt1273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019548326
    175 https://doi.org/10.1038/nbt1273
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1038/nbt1284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045526065
    178 https://doi.org/10.1038/nbt1284
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1038/nrd1343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040452458
    181 https://doi.org/10.1038/nrd1343
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.1038/nrd892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046818756
    184 https://doi.org/10.1038/nrd892
    185 rdf:type schema:CreativeWork
    186 sg:pub.10.1038/sj.cdd.4401910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045481166
    187 https://doi.org/10.1038/sj.cdd.4401910
    188 rdf:type schema:CreativeWork
    189 grid-institutes:grid.266102.1 schema:alternateName Department of Cellular and Molecular Pharmacology, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA
    190 Graduate Group in Biophysics, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA
    191 schema:name Department of Cellular and Molecular Pharmacology, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA
    192 Department of Pharmaceutical Chemistry, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA
    193 Graduate Group in Biophysics, University of California at San Francisco, 1700 4th Street 503A, 94156, San Francisco, California, USA
    194 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...